← FDA Drug Approvals (Drugs@FDA)

EXEMESTANE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2022-05-20

Drug application

FDA Application #

ANDA216454

Application type

Abbreviated New Drug Application (Generic)

Brand name

EXEMESTANE

Generic name

EXEMESTANE

Active ingredients

EXEMESTANE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

EUGIA PHARMA

Manufacturer

Aurobindo Pharma Limited

First approval

2022-05-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown